Drug intelligence / Profile preview

avobenzone + oxybenzone + ecamsule + octocrylene + homosalate + octisalate + octinoxate aerosol spray

Development stage
Unknown
Lead developer
U.S. Food & Drug Administration
Modality
Small Molecules
Administration
Topical
01

Overview

This refers to an aerosol spray sunscreen formulation containing a combination of chemical UV filters, including avobenzone, oxybenzone, ecamsule, octocrylene, homosalate, octisalate, and octinoxate. It was evaluated by the U.S. Food and Drug Administration (FDA) in a Phase 1 maximal usage trial (MUsT), specifically NCT03582215, to investigate the systemic absorption and pharmacokinetics of these active ingredients when applied under conditions of high-volume topical use. These ingredients function as sunscreen agents by absorbing ultraviolet (UV) radiation, thereby protecting the skin from sunburn and long-term damage such as photoaging and skin cancer. The study aimed to determine if plasma concentrations of these filters exceed the FDA's safety threshold of 0.5 ng/mL, which would trigger further nonclinical safety assessments.

Other names
FDA MUsT Aerosol SpraySunscreen Aerosol Spray (NCT03582215)

Beyond the preview

Go deeper on avobenzone + oxybenzone + ecamsule + octocrylene + homosalate + octisalate + octinoxate aerosol spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on avobenzone + oxybenzone + ecamsule + octocrylene + homosalate + octisalate + octinoxate aerosol spray.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call